Cargando…

A rare entity to major outbreak: a case report on mucormycosis

Mucormycosis is relatively uncommon, fulminant, progressive, life threatening fungal disease which is most often seen in debilitating patients with immunocompromised condition. Mucormycosis cases are seen in patients with the use of systemic steroids in the treatment of severely affected COVID-19 ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Dhaman, Dosi, Tanvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449572/
https://www.ncbi.nlm.nih.gov/pubmed/34584608
http://dx.doi.org/10.11604/pamj.2021.39.183.30479
_version_ 1784569448999419904
author Gupta, Dhaman
Dosi, Tanvi
author_facet Gupta, Dhaman
Dosi, Tanvi
author_sort Gupta, Dhaman
collection PubMed
description Mucormycosis is relatively uncommon, fulminant, progressive, life threatening fungal disease which is most often seen in debilitating patients with immunocompromised condition. Mucormycosis cases are seen in patients with the use of systemic steroids in the treatment of severely affected COVID-19 cases and also in the patients with uncontrolled diabetes which causes immunosuppression are being reported with mucormycosis. The main symptoms of this disease include pain on the temporal and the orbital region of the affected side which could be throbbing or lancinating type, mobility of the teeth, jaw pain and often swelling is present which could be extraoral and intraoral both or sometimes only intraorally. The diagnostic approach in such cases is done with the help of clinical diagnosis, histopathology and with advanced imaging like cone beam computed tomography, magnetic resonance imaging and computed tomography. We here used cone beam computed tomography imaging that revealed haziness in the sinuses and breach in cortical bone of the affected area which confirmed the diagnosis of mucormycosis. Early treatment planning like administration of antifungal drugs and surgical debridement will be life saving in such a deadly disease.
format Online
Article
Text
id pubmed-8449572
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-84495722021-09-27 A rare entity to major outbreak: a case report on mucormycosis Gupta, Dhaman Dosi, Tanvi Pan Afr Med J Case Report Mucormycosis is relatively uncommon, fulminant, progressive, life threatening fungal disease which is most often seen in debilitating patients with immunocompromised condition. Mucormycosis cases are seen in patients with the use of systemic steroids in the treatment of severely affected COVID-19 cases and also in the patients with uncontrolled diabetes which causes immunosuppression are being reported with mucormycosis. The main symptoms of this disease include pain on the temporal and the orbital region of the affected side which could be throbbing or lancinating type, mobility of the teeth, jaw pain and often swelling is present which could be extraoral and intraoral both or sometimes only intraorally. The diagnostic approach in such cases is done with the help of clinical diagnosis, histopathology and with advanced imaging like cone beam computed tomography, magnetic resonance imaging and computed tomography. We here used cone beam computed tomography imaging that revealed haziness in the sinuses and breach in cortical bone of the affected area which confirmed the diagnosis of mucormycosis. Early treatment planning like administration of antifungal drugs and surgical debridement will be life saving in such a deadly disease. The African Field Epidemiology Network 2021-07-07 /pmc/articles/PMC8449572/ /pubmed/34584608 http://dx.doi.org/10.11604/pamj.2021.39.183.30479 Text en Copyright: Dhaman Gupta et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gupta, Dhaman
Dosi, Tanvi
A rare entity to major outbreak: a case report on mucormycosis
title A rare entity to major outbreak: a case report on mucormycosis
title_full A rare entity to major outbreak: a case report on mucormycosis
title_fullStr A rare entity to major outbreak: a case report on mucormycosis
title_full_unstemmed A rare entity to major outbreak: a case report on mucormycosis
title_short A rare entity to major outbreak: a case report on mucormycosis
title_sort rare entity to major outbreak: a case report on mucormycosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449572/
https://www.ncbi.nlm.nih.gov/pubmed/34584608
http://dx.doi.org/10.11604/pamj.2021.39.183.30479
work_keys_str_mv AT guptadhaman arareentitytomajoroutbreakacasereportonmucormycosis
AT dositanvi arareentitytomajoroutbreakacasereportonmucormycosis
AT guptadhaman rareentitytomajoroutbreakacasereportonmucormycosis
AT dositanvi rareentitytomajoroutbreakacasereportonmucormycosis